In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 48 for your search:
Drug:  gemtuzumab ozogamicin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Natural history/Epidemiology
Status: Completed
Age: 18 to 65
Sponsor: Pharmaceutical / Industry
Protocol IDs: 0903X-100847, NCT00161668

2.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: LAP-R2007, NCT00504764

3.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Any age
Sponsor: Other
Protocol IDs: PETHEMA-LAM07, NCT01041040

4.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Unknown
Age: Any age
Sponsor: Other
Protocol IDs: UHW-AML16, EU-20677, ISRCTN11036523, EUDRACT-2005-002846-14, MREC-CU106, NCT00454480

5.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: MYFLAI07, NCT00909168

6.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 60
Sponsor: NCI, Other
Protocol IDs: CDR0000258113, U10CA021115, E1900, ECOG-1900, NCT00049517

7.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 61 to 75
Sponsor: Other
Protocol IDs: EORTC-06012, AML-17, GIMEMA-AML-17, NCT00052299

8.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 60
Sponsor: NCI, Other
Protocol IDs: CDR0000360812, U10CA032102, S0106, SWOG-S0106, NCT00085709

9.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 61 and over
Sponsor: Other
Protocol IDs: CDR0000433422, SAKK-AML-43, EU-20514, HOVON-AML-43, NCT00121303

10.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI, Other
Protocol IDs: AML02, 5R01CA113482, NCT00136084

11.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 30
Sponsor: NCI, Other
Protocol IDs: AAML0531, COG-AAML0531, CDR0000487497, NCT00372593

12.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000553210, S0521, U10CA032102, SWOG-S0521, NCT00492856

13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and under
Sponsor: Other
Protocol IDs: NOPHO-AML 2004, NCT00476541

14.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 60
Sponsor: Other
Protocol IDs: BRD 06/10-I, NCT00860639

15.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 50 to 70
Sponsor: Other
Protocol IDs: ALFA 0701, NCT00927498

16.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 55 to 75
Sponsor: Other
Protocol IDs: ID01-010, NCT00038831

17.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: KAN-979-02, NCT00233909

18.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 90
Sponsor: Other
Protocol IDs: 090516, NCT00766116

19.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 50 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01147, IR-6921, CDR0000642213, 2288.00, 8297, P30CA015704, FHCRC-2288.00, NCT00895934

20.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 60 and over
Sponsor: NCI, Other
Protocol IDs: 2413.00, NCI-2010-01253, K12CA076930, NCT01141725

21.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: W-AR-0903B1-201-US, CDR0000065896, UCCRC-8600, NCI-V97-1355, NCT00003131

22.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 60 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: W-AR-0903B1-203-US, CDR0000066771, NCI-V98-1497, NCT00003673

23.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067944, E-4999, NCT00005962

24.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 61 and over
Sponsor: Other
Protocol IDs: EORTC-06993, EORTC-06993-AML-15, NCT00006122

25.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 17 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068208, U10CA031946, CALGB-19902, NCT00006265
1   
New Search